Anti-NODAL Modulator 2 antibodies are used for the immunodetection of the protein encoded by the NOMO2 gene. In humans, the canonical protein has a reported length of 1267 amino acid residues and a mass of 139.4 kDa. Its subcellular localization is in the ER. Alternative splicing is reported to yield 3 different isoforms for this protein. It is reported to be highly expressed in the pancreas and skeletal muscle and, at lower levels, in the heart. It is a known component of the multi-pass translocon (MPT) complex that mediates insertion of multi-pass membrane proteins into the lipid bilayer of membranes. Post-translational modifications have been described, including glycosylation. Other names for this target antigen include PM5, BOS complex subunit NOMO2, pM5 protein 2, pM5 protein, centromeric copy, and Nomo. Some NODAL Modulator 2 antibodies may have been used in research and have associated citations. These antibodies are most commonly used in Western Blot experiments, among other applications.